Pegasystems (PEGA) Receives Analyst Rating

Pegasystems (PEGA) : Zacks Investment Research ranks Pegasystems (PEGA) as 4, which is a Sell recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 2 research analysts is 2, which indicates as a Buy.

Pegasystems (PEGA) : The highest short term price target forecast on Pegasystems (PEGA) is $32 and the lowest target price is $26. A total of 2 equity analysts are currently covering the company. The average price of all the analysts is $29 with a standard deviation of $4.24.


Pegasystems (NASDAQ:PEGA): After opening at $27.29, the stock dipped to an intraday low of $26.621 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $27.91 and the buying power remained strong till the end. The stock closed at $27.87 for the day, a gain of 1.64% for the day session. The total traded volume was 455,800. The stocks close on the previous trading day was $27.42.

Pegasystems Inc. develops, markets, licenses and supports software applications, which is designed to assist clients in building, deploying and evolving enterprise applications. The Companys applications and platform intersect with and encompass several traditional software markets, including Customer Relationship Management (CRM); Business Process Management (BPM); Business Rules Management Systems (BRMS); Dynamic Case Management (DCM); Decision Management, which includes Predictive and Adaptive analytics, and the Vertical Specific Software (VSS) market of industry solutions and packaged applications. The Company provides implementation, consulting, training, technical support and hosting services to facilitate the use of its software. The Company offers its services to financial services, healthcare, insurance, communications and media, public sector, manufacturing and life sciences markets.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *